FINWIRES · TerminalLIVE
FINWIRES

$AMRX

5 stories mentioning AMRX

Every FINWIRES story that references AMRX, newest first.

Sectors

Sector Update: Healthcare

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index increasing 1.4% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%.The iShares Biotechnology ETF (IBB) declined 0.5%.In corporate news, Amneal Pharmaceuticals (AMRX) said Friday that interim results from its phase 4 study of Crexont to treat Parkinson's disease demonstrated substantial clinical benefit after patients switched to the drug from Rytary. Amneal Pharmaceuticals' shares rose 2.1%.

$AMRX
Sectors

Sector Update: Healthcare Stocks Rise Premarket Friday

Healthcare stocks were rising premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.7% and the iShares Biotechnology ETF (IBB) 0.3% higher.Amneal Pharmaceuticals (AMRX) stock was up more than 2% after the company said interim results from its phase 4 study of Crexont to treat Parkinson's disease demonstrated substantial clinical benefit after patients switched to the drug from Rytary.BioCardia (BCDA) has received confirmation from the US Food and Drug Administration that its ongoing heart failure trial may support a premarket approval of the CardiAMP Cell Therapy System for the treatment of ischemic heart failure with reduced ejection fraction, the company said. Shares of BioCardia were up more than 33% pre-bell.

$AMRX$BCDA$IBB$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were rising premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.7% and the iShares Biotechnology ETF (IBB) 0.3% higher.Amneal Pharmaceuticals (AMRX) stock was up more than 1% after the company said interim results from its phase 4 study of Crexont to treat Parkinson's disease demonstrated substantial clinical benefit after patients switched to the drug from Rytary.

$AMRX
Sectors

Sector Update: Healthcare Stocks Rise Premarket Thursday

Healthcare stocks were rising premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1.5% higher and the iShares Biotechnology ETF (IBB) advancing by 0.6%.Biogen (BIIB) shares were up more than 1% after the company said the US Food and Drug Administration has granted breakthrough therapy designation for Salanersen to treat spinal muscular atrophy, a rare, genetic and neuromuscular disease.Royal Philips (PHG) and WellSpan Health said they have entered into a seven-year partnership focused on research, innovation, and the deployment of advanced imaging and diagnostic technologies across WellSpan's network. Shares of Royal Philips were up more than 1% pre-bell.Amneal Pharmaceuticals (AMRX) stock was 1% higher after the company said has received the US Food and Drug Administration's approval for its romidepsin injection solution.

$AMRX$BIIB$IBB$PHG$XLV
Research

UBS Initiates Amneal Pharmaceuticals at Buy With $19 Price Target

Amneal Pharmaceuticals (AMRX) has an average rating of buy and mean price target of $17.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$AMRX